Daxor Return on Investment 2010-2011 | DXR
Current and historical return on investment (ROI) values for Daxor (DXR) over the last 10 years.
| Daxor ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2011-12-31 | $-0.01B | inf% | |
| 2011-09-30 | $-0.01B | inf% | |
| 2011-06-30 | $-0.01B | inf% | |
| 2011-03-31 | $-0.01B | inf% | |
| 2010-12-31 | $-0.01B | inf% | |
| 2010-09-30 | $-0.01B | inf% | |
| 2010-06-30 | $-0.01B | inf% | |
| 2010-03-31 | $-0.00B | inf% | |
| 2009-12-31 | $-0.00B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.044B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.240B | 12.24 |
| Quest Diagnostics (DGX) | United States | $17.529B | 17.81 |
| DaVita (DVA) | United States | $13.689B | 16.84 |
| Encompass Health (EHC) | United States | $9.609B | 23.64 |
| Chemed (CHE) | United States | $8.933B | 27.47 |
| Elanco Animal Health (ELAN) | United States | $6.258B | 14.07 |
| Option Care Health (OPCH) | United States | $5.189B | 25.50 |
| RadNet (RDNT) | United States | $4.999B | 118.58 |
| Amedisys (AMED) | United States | $3.177B | 22.73 |
| Astrana Health (ASTH) | United States | $2.842B | 40.21 |
| LifeStance Health (LFST) | United States | $2.782B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.354B | 28.59 |
| U.S Physical Therapy (USPH) | United States | $1.250B | 33.83 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.024B | 0.00 |
| Pennant (PNTG) | United States | $1.010B | 48.32 |
| Atai Life Sciences (ATAI) | Germany | $0.215B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.026B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.015B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.009B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.004B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |